Using @RISK in Evaluating Full (late stage) Compound Development in the Pharmaceutical Industry

Venkat Raman
VR Advisors LLC

This free live webcast will discuss the financial evaluation of late stage development of compound in the pharmaceutical industry, but the rational, methodology and analysis discussed here has universal applicability to any multi-stage product development activities across industries. We will not discuss the real options analysis here, as this is not the intended objective of this presentation. But the webcast will:

• Present the case - a miniature model of a full-blown real world case
• Discuss the two financial models – the deterministic and the probabilistic models
• Frame the case
• Model the case
• Discuss insights and results